BIOA
BIOA clinical trials: BioAge Labs, Inc.
Every trial on ClinicalTrials.gov where BioAge Labs, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
BIOA on the catalyst calendar · BIOA registry changes
- Primary completion Nov 2027Sponsor estimatePhase 2NCT07812090A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular EdemaBioAge Labs, Inc. · Diabetic Macular Edema (DME)RecruitingBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2026Sponsor estimatePhase 2NCT07656727A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular...BioAge Labs, Inc. · Obesity and Cardiovascular RiskActive, not recruitingBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 6, 2025ActualPhase 2NCT06515418Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55...BioAge Labs, Inc. · ObesityTerminatedBIOALeadLLYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 26, 2024ActualPhase 1NCT06141889Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy VolunteersBioAge Labs, Inc. · Healthy Volunteer StudyCompletedBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2022ActualPhase 2NCT04705597Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That...BioAge Labs, Inc. · Covid19TerminatedBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2023Sponsor estimatePhase 2NCT05152641Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip SurgeryBioAge Labs, Inc. · Acute Posthemorrhagic AnemiaWithdrawnBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2022Sponsor estimatePhase 2NCT04815603Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of AgingBioAge Labs, Inc. · AnemiaWithdrawnBIOALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner